Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Demineralized dental enamel lesion describes areas of tooth enamel that have lost essential minerals, mostly calcium and phosphate, resulting in subsurface porosity and heightened susceptibility to dental caries[1][6][10]. The process is initiated by acids—mainly lactic acid—produced by bacterial fermentation of dietary carbohydrates within dental plaque, or by exposure to dietary or endogenous acids (e.g., gastric reflux)[1][5][6]. The earliest clinical sign is a "white spot lesion," which marks regions of subsurface mineral loss, often reversible if promptly remineralized with fluoride or calcium-phosphate therapies[9]. If unchecked, demineralization progresses to cavitated lesions, compromising tooth structure and often leading to caries, pain, and, potentially, infection[1][10]. Interventions focus on modulating the dynamic between demineralization and remineralization of enamel using topical agents and dietary changes[5][10][6].
Promotes remineralization by replenishing calcium, phosphate, or fluoride ions; Inhibits bacterial acid production; Forms acid-resistant mineral phases in enamel (fluorapatite)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Demineralized dental enamel lesion.